Impact of cyclooxygenase-2 in breast cancer

Anticancer Res. 2011 Dec;31(12):4359-67.

Abstract

Prostaglandin metabolism plays a pivotal role in inflammatory processes and has also been demonstrated to have a role in carcinogenesis, tumor differentiation and tumor growth in breast cancer. Cyclooxygenase-2 (COX-2) is the key involved enzyme, as it triggers prostaglandin synthesis. We reviewed the current literature regarding the impact of prostaglandin metabolism on breast cancer and illustrated the current evidence of the COX-2 influence on breast cancer, delineating possible future prophylactic and therapeutic strategies.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Biomarkers, Tumor
  • Breast Neoplasms / metabolism*
  • Cell Line, Tumor
  • Cyclooxygenase 2 / biosynthesis
  • Cyclooxygenase 2 / physiology*
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation, Enzymologic*
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Immunohistochemistry / methods
  • Mice
  • Mice, Knockout
  • Neoplasm Metastasis
  • Prognosis
  • Prostaglandins / metabolism

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Biomarkers, Tumor
  • Prostaglandins
  • Cyclooxygenase 2